Ubs Oconnor LLC Alector, Inc. Transaction History
Ubs Oconnor LLC
- $1.51 Billion
- Q4 2024
A detailed history of Ubs Oconnor LLC transactions in Alector, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 50,000 shares of ALEC stock, worth $93,500. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$93,500% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ALEC
# of Institutions
155Shares Held
55MCall Options Held
39.7KPut Options Held
51K-
Ra Capital Management, L.P. Boston, MA9.7MShares$18.1 Million0.3% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$17 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$10.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.91MShares$3.58 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$3.46 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $154M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...